Levy Richard S sold 439 shares of MADRIGAL PHARMACEUTICALS, INC. at $512.50 for −$225k on May 22, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Director
DIR
Filed May 22, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$224,988.47Shares × reported price
Shares traded
439Common Stock
Price per share
$512.50Reported price. Read footnotes for ranges.
% of reported position traded
1.65%This security and ownership context
Holdings after
26,137Direct
Trade date
May 22, 2026Sell
Filed
May 22, 2026, 6:01 PM ET0-day reporting delay
Accession
0001628280-26-037830Code S · Transaction 383639
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 26,576 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Related trades are temporarily unavailable. Open the SEC filing for the complete report, or reload this page.

MDGL price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MDGL · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +2.3%1w ago +1.2%1d ago −0.7%
Returns since7d −3.9%30d −2.2%90d +0.4%180d1y

Footnotes in full

F1: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $506.42 to $507.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $508.11 to $508.89, inclusive. F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $509.89 to $510.85, inclusive. F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $510.89 to $511.87, inclusive. F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $511.91 to $512.88, inclusive. F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $514.17 to $515.16, inclusive. F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $515.26 to $516.22, inclusive. F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $516.28 to $517.27, inclusive. F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $517.28 to $518.27, inclusive. F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $518.30 to $519.29, inclusive. F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $519.68 to $520.28, inclusive.